➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
AstraZeneca
Baxter
Medtronic

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

DEXAMETHASONE SODIUM PHOSPHATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Dexamethasone Sodium Phosphate patents expire, and what generic alternatives are available?

Dexamethasone Sodium Phosphate is a drug marketed by Akorn, Amneal, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset, Somerset Theraps Llc, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz Inc. and is included in thirty-five NDAs.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

US ANDA Litigation and Generic Entry Outlook for Dexamethasone Sodium Phosphate

A generic version of DEXAMETHASONE SODIUM PHOSPHATE was approved as dexamethasone sodium phosphate by WEST-WARD PHARMS INT on September 7th, 1982.

  Start Trial

Drug patent expirations by year for DEXAMETHASONE SODIUM PHOSPHATE
Recent Clinical Trials for DEXAMETHASONE SODIUM PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ocular TherapeutixPhase 4
New England Retina AssociatesPhase 4
Weill Medical College of Cornell UniversityPhase 1

See all DEXAMETHASONE SODIUM PHOSPHATE clinical trials

Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE

US Patents and Regulatory Information for DEXAMETHASONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OTIC 084855-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sola Barnes Hind DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 084170-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 208690-001 Aug 22, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Sola Barnes Hind DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 084173-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
AstraZeneca
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.